Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HERVH-derived eRNA activates a super-enhancer-driven ALDH1A3/SAT1 axis to promote ferroptosis escape and pancreatic cancer development. | Sci Adv | 2025 | 41370380 | PubTator, text mining | PubMed |
| Gut Microbiota and Ferroptosis in Colorectal Cancer: A Comprehensive Review of Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Resistance. | Biomolecules | 2025 | 41301464 | PubTator, text mining | PubMed |
| ONECUT2-driven activation of ADAMTS14 boosts colorectal cancer stemness via Wnt pathway. | Hum Cell | 2025 | 41225269 | PubTator, text mining | PubMed |
| Development of retinoid nuclear receptor pathway antagonists through targeting aldehyde dehydrogenase 1A3. | iScience | 2025 | 41210994 | PubTator, text mining | PubMed |
| SETD7-mediated H3K4me1 activates ALDH1A3 to drive ferroptosis resistance in esophageal squamous cell carcinoma. | Cell Death Dis | 2025 | 41203594 | PubTator, text mining | PubMed |
| PKCζ, CTNNBIP1 and ALDH1A3 Expression in Luminal B Breast Cancer Indicates Decreased Hormone Therapy Effectiveness. | Cancer Diagn Progn | 2025 | 41179319 | PubTator, text mining | PubMed |
| High p62 and ALDH1A3 Reduce the Effectiveness of Endocrine Therapy in Luminal B Breast Cancer. | Cancer Diagn Progn | 2025 | 41179310 | PubTator, text mining | PubMed |
| Protein truncating splice site variant in ALDH1A3 associated with bilateral anophthalmia identified in a multiplex consanguineous Pakistani family. | Int J Ophthalmol | 2025 | 41158164 | PubTator, text mining | PubMed |
| Integrated Approach of Machine Learning and High-Throughput Screening to Identify Chemical Probe Candidates Targeting Aldehyde Dehydrogenases. | ACS Pharmacol Transl Sci | 2025 | 41098570 | PubTator, text mining | PubMed |
| Insufficient NNMT promotes autophagy and disrupts progesterone signaling in endometrial stromal cells in recurrent implantation failure by modulating the H3K9me3-ALDH1A3 pathway. | Cell Death Discov | 2025 | 41057307 | PubTator, text mining | PubMed |
| Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors. | Cell Chem Biol | 2025 | 41033308 | PubTator, text mining | PubMed |
| High Expression of PKCζ and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer. | Anticancer Res | 2025 | 41006005 | PubTator, text mining | PubMed |
| Oxidative Stress and Antioxidant Therapies in Friedreich's Ataxia. | Cells | 2025 | 41002373 | PubTator, text mining | PubMed |
| Advances and Deep Insights Into Lactylation: Essential Roles in Cellular Regulation and Disease Association. | J Cell Mol Med | 2025 | 40984037 | PubTator, text mining | PubMed |
| An Epigenomic Meta-Analysis of Differentially Methylated Sites in Pre- and Post-Metabolic/Bariatric Surgery Adult Female Patients. | Epigenomes | 2025 | 40981068 | PubTator, text mining | PubMed |
| β-cell dedifferentiation in type 2 diabetes: Interplay of metabolic stress, endoplasmic reticulum dysfunction, and forkhead box protein O1 inhibition. | World J Diabetes | 2025 | 40980299 | PubTator, text mining | PubMed |
| Multi-omics analysis and metastasis risk factor prediction in N1b stage PTMC: insights into immune infiltration and therapeutic implications. | Front Immunol | 2025 | 40977710 | PubTator, text mining | PubMed |
| The gut microbiota directs vitamin A flux to regulate intestinal T cell development. | bioRxiv | 2025 | 40964372 | PubTator, text mining | PubMed |
| Discovery of a reversible ALDH1A3 inhibitor throwugh a consensus docking-based virtual screening study. | J Comput Aided Mol Des | 2025 | 40887554 | PubTator, text mining | PubMed |
| Roles and Prospective Applications of Ferroptosis Suppressor Protein 1 (FSP1) in Malignant Tumor Treatment. | Curr Oncol | 2025 | 40862825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=3